Weiss Multi-Strategy Advisers’s Insmed INSM Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-70,000	Closed	-$2.17M	–	241
2023 Q4	$2.17M	Buy	70,000 +31,770	+83%	+$824K	0.05%	361
2023 Q3	$965K	Sell	38,230 -28,673	-43%	-$656K	0.02%	435
2023 Q2	$1.41M	Sell	66,903 -60,862	-48%	-$1.15M	0.03%	516
2023 Q1	$2.18M	Sell	127,765 -14,667	-10%	-$285K	0.05%	410
2022 Q4	$2.85M	Buy	142,432 +52,320	+58%	+$1.01M	0.08%	327
2022 Q3	$1.94M	Sell	90,112 -10,000	-10%	-$240K	0.05%	406
2022 Q2	$1.97M	Buy	100,112 +49,112	+96%	+$1.03M	0.06%	392
2022 Q1	$1.2M	Buy	51,000 +5,355	+12%	+$124K	0.03%	478
2021 Q4	$1.24M	Buy	45,645 +1,645	+4%	+$47K	0.03%	448
2021 Q3	$1.21M	Buy	44,000 +17,014	+63%	+$446K	0.03%	479
2021 Q2	$768K	Buy	26,986 +3,875	+17%	+$115K	0.02%	520
2021 Q1	$787K	Sell	23,111 -931	-4%	-$35.6K	0.02%	513
2020 Q4	$800K	Sell	24,042 -21,042	-47%	-$769K	0.02%	513
2020 Q3	$1.45M	Sell	45,084 -24,142	-35%	-$694K	0.04%	384
2020 Q2	$1.91M	Buy	69,226 +15,226	+28%	+$361K	0.05%	342
2020 Q1	$866K	Buy	54,000 +9,000	+20%	+$213K	0.03%	314
2019 Q4	$1.07M	Buy	45,000 +6,000	+15%	+$122K	0.02%	483
2019 Q3	$688K	Buy	39,000 +9,000	+30%	+$174K	0.01%	470
2019 Q2	$768K	Sell	30,000 -12,000	-29%	-$334K	0.02%	396
2019 Q1	$1.22M	Buy	42,000 +32,000	+320%	+$829K	0.03%	371
2018 Q4	$131K	Sell	10,000 -20,000	-67%	-$319K	0.01%	422
2018 Q3	$607K	Sell	30,000 -48,000	-62%	-$1.08M	0.02%	429
2018 Q2	$1.84M	Buy	78,000 +8,000	+11%	+$206K	0.04%	359
2018 Q1	$1.58M	Buy	70,000 +20,000	+40%	+$526K	0.05%	364
2017 Q4	$1.56M	Sell	50,000 -25,000	-33%	-$739K	0.04%	380
2017 Q3	$2.34M	Buy	+75,000	New	+$1.43M	0.09%	288
2015 Q2	–	Sell	-25,000	Closed	-$520K	–	482
2015 Q1	$520K	Buy	+25,000	New	+$440K	0.02%	359
2014 Q2	–	Sell	-12,100	Closed	-$230K	–	819
2014 Q1	$230K	Buy	12,100 +970	+9%	+$18.4K	﹤0.01%	882
2013 Q4	$189K	Sell	11,130 -28,870	-72%	-$442K	﹤0.01%	910
2013 Q3	$624K	Sell	40,000 -55,000	-58%	-$699K	0.01%	492
2013 Q2	$1.14M	Buy	+95,000	New	+$971K	0.03%	372

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Weiss Multi-Strategy Advisers's INSM Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Insmed (INSM) in Q1 2024, closing a stake of 70,000 shares — an estimated $2.17M sold.

Weiss Multi-Strategy Advisers first reported a position in INSM in Q2 2013 and held it in 31 quarters. The position peaked at $2.85M in Q4 2022. 288 funds tracked by Wall St. Rank hold INSM as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Insmed position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 70,000 Insmed shares in Q1 2024, an estimated $2.17M.
Weiss Multi-Strategy Advisers first reported a position in Insmed in Q2 2013 and held it in 31 quarters.
Weiss Multi-Strategy Advisers's Insmed position peaked at $2.85M in Q4 2022.
288 funds tracked by Wall St. Rank held Insmed as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.